Lynn E. Bayless
General Counsel bij MUSTANG BIO, INC.
Profiel
Lynn E.
Bayless is a professional with experience in regulatory affairs.
Currently, Bayless is the Head of Regulatory Affairs at Mustang Bio, Inc. Prior to this, Bayless held the position of Senior Director of Regulatory Affairs at Nightstar Therapeutics Ltd.
from 2018 to 2020.
From 2015 to 2018, Bayless worked as the Director of Regulatory Affairs at Voyager Therapeutics, Inc. Bayless has an undergraduate degree from Quinnipiac University and a graduate degree from Massachusetts College of Pharmacy & Health Science.
Actieve functies van Lynn E. Bayless
| Bedrijven | Functie | Begin |
|---|---|---|
| MUSTANG BIO, INC. | General Counsel | 01-01-2020 |
Eerdere bekende functies van Lynn E. Bayless
| Bedrijven | Functie | Einde |
|---|---|---|
| NIGHTSTAR THERAPEUTICS PLC | General Counsel | 01-02-2020 |
| VOYAGER THERAPEUTICS, INC. | General Counsel | 01-10-2018 |
Opleiding van Lynn E. Bayless
| Massachusetts College of Pharmacy & Health Science | Graduate Degree |
| Quinnipiac University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| MUSTANG BIO, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
